Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
Castaman
G
G
Eikenboom
J C
JC
Contri
A
A
Rodeghiero
F
F
D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage; D005169:Factor VIII / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006579:Heterozygote; D006801:Humans; D020125:Mutation, Missense; D010641:Phenotype; D017354:Point Mutation / Q000235:genetics*; D006473:Postpartum Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D014842:von Willebrand Diseases / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D014841:von Willebrand Factor / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism
D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin